| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Biowatch Alert: Heska Jumps On 5x Volume, No News
Posted on 04/16/2007 10:43:31 | Link | Post Comment
by H.S. Ayoub
BioHealthInvestor.com
Shares of Heska Corporation (HSKA) gained 7% on Friday as volume was more than five times the 3 month daily average.
There were no significant news releases or other significant events that could be detected.
Heska engages in the discovery, development, manufacture, marketing, sale, distribution, and support of veterinary products primarily in the United States and Europe. The company operates in two segments, Core Companion Animal Health, and Other Vaccines Pharmaceuticals and Products.
The company is tiny, having a market cap of only $92 million. It has over $5 million in cash and more than $11 million in debt according to the latest Yahoo! financial data. Revenues and earnings have been increasing yearly over the last few years. Company insiders have been buying shares on a regular basis over a two year span.
Shares of Heska closed at $1.82 on Friday, just under the 52-week high of $1.90.
Heska has made BHI's BioWatch Alert List, and will be tracked for the next two weeks.
Source: BioHealthInvestor.com
_____________________
BioHealthInvestor.com
Shares of Heska Corporation (HSKA) gained 7% on Friday as volume was more than five times the 3 month daily average.
There were no significant news releases or other significant events that could be detected.
Heska engages in the discovery, development, manufacture, marketing, sale, distribution, and support of veterinary products primarily in the United States and Europe. The company operates in two segments, Core Companion Animal Health, and Other Vaccines Pharmaceuticals and Products.
The company is tiny, having a market cap of only $92 million. It has over $5 million in cash and more than $11 million in debt according to the latest Yahoo! financial data. Revenues and earnings have been increasing yearly over the last few years. Company insiders have been buying shares on a regular basis over a two year span.
Shares of Heska closed at $1.82 on Friday, just under the 52-week high of $1.90.
Heska has made BHI's BioWatch Alert List, and will be tracked for the next two weeks.
Source: BioHealthInvestor.com
_____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
Examples
ATM Wallstreet - Mon Oct 06, 2008 03:39PM
Made several great trades today. Traded the QID, QQ [read more]
Made several great trades today. Traded the QID, QQ [read more]
ATM Wallstreet - Sat Oct 04, 2008 10:41PM
When I first started Day Trading I traded anything that [read more]
When I first started Day Trading I traded anything that [read more]
Morpheus Trading - Thu Oct 02, 2008 08:58AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
<< My Home | TheMoneyBlogs Home